Cargando…

Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’

Medical aid in dying is the act of prescribing lethal medications to a consenting patient who can self-ingest them with the intent of hastening their death. A majority of patients who utilize medical aid in dying are patients with terminal cancer. As oncology patients continue to choose deaths most...

Descripción completa

Detalles Bibliográficos
Autor principal: Lawry, Dallas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258856/
https://www.ncbi.nlm.nih.gov/pubmed/37313278
http://dx.doi.org/10.6004/jadpro.2023.14.4.5
_version_ 1785057549753516032
author Lawry, Dallas R.
author_facet Lawry, Dallas R.
author_sort Lawry, Dallas R.
collection PubMed
description Medical aid in dying is the act of prescribing lethal medications to a consenting patient who can self-ingest them with the intent of hastening their death. A majority of patients who utilize medical aid in dying are patients with terminal cancer. As oncology patients continue to choose deaths most suitable to them, it is critical that advanced practitioners in oncology be knowledgeable regarding this end-of-life decision. With 40 states denying patients access to medical aid in dying, the purpose of this end-of-life care review is not to persuade for or against medical aid in dying, active euthanasia, or other forms of dying with dignity, but rather to shed light on patient decisions and available end-of-life options for patients where medical aid in dying is not honored. One author has succinctly named this era as “Dying in the Age of Choice,” and therefore the purpose of this article is to present the current state of medical aid in dying. The article presents case studies for the reader, as well as a comparison of California's statistics with the national average. Much like other controversial subjects that intersect morality, religion, and Hippocratic medical ethics, practitioners in the healing arts must remain unbiased and honor the wishes of patients even when they differ from their own. In serving the population with the highest utilization of medical aid in dying, advanced practitioners in oncology should be familiar with the legal specifications in their state or be abreast of solutions for guiding patients through end of life in the states where medical aid in dying remains illegal.
format Online
Article
Text
id pubmed-10258856
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-102588562023-06-13 Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’ Lawry, Dallas R. J Adv Pract Oncol Review Medical aid in dying is the act of prescribing lethal medications to a consenting patient who can self-ingest them with the intent of hastening their death. A majority of patients who utilize medical aid in dying are patients with terminal cancer. As oncology patients continue to choose deaths most suitable to them, it is critical that advanced practitioners in oncology be knowledgeable regarding this end-of-life decision. With 40 states denying patients access to medical aid in dying, the purpose of this end-of-life care review is not to persuade for or against medical aid in dying, active euthanasia, or other forms of dying with dignity, but rather to shed light on patient decisions and available end-of-life options for patients where medical aid in dying is not honored. One author has succinctly named this era as “Dying in the Age of Choice,” and therefore the purpose of this article is to present the current state of medical aid in dying. The article presents case studies for the reader, as well as a comparison of California's statistics with the national average. Much like other controversial subjects that intersect morality, religion, and Hippocratic medical ethics, practitioners in the healing arts must remain unbiased and honor the wishes of patients even when they differ from their own. In serving the population with the highest utilization of medical aid in dying, advanced practitioners in oncology should be familiar with the legal specifications in their state or be abreast of solutions for guiding patients through end of life in the states where medical aid in dying remains illegal. Harborside Press LLC 2023-05 2023-05-01 /pmc/articles/PMC10258856/ /pubmed/37313278 http://dx.doi.org/10.6004/jadpro.2023.14.4.5 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Lawry, Dallas R.
Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
title Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
title_full Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
title_fullStr Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
title_full_unstemmed Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
title_short Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
title_sort rethinking medical aid in dying: what does it mean to ‘do no harm?’
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258856/
https://www.ncbi.nlm.nih.gov/pubmed/37313278
http://dx.doi.org/10.6004/jadpro.2023.14.4.5
work_keys_str_mv AT lawrydallasr rethinkingmedicalaidindyingwhatdoesitmeantodonoharm